Onychomycosis Treatment Market By Treatment Type (Medication-Based Treatments and Device-Based Treatments), By Pathogen Type (Dermatophytes, Non-Dermatophyte Molds & Yeasts), By Disease Type (Distal Subungual Onychomycosis (DSO), Proximal Subungual Onychomycosis, White Superficial Onychomycosis & Candidal Onychomycosis), By Distribution Channels (Retail Pharmacies, Online Pharmacies, and Hospitals and Clinics), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Aug 2025
- Report ID: 154899
- Number of Pages: 301
- Format:
-
keyboard_arrow_up
-
-
- Bausch Health Companies Inc.
- Galderma S.A.
- Novartis AG
- Pfizer Inc.
- Moberg Pharma AB
- Cipla Limited
- Reddy’s Laboratories Ltd.
- GlaxoSmithKline plc (GSK)
- Kaken Pharmaceutical Co., Ltd.
- Merz Pharma
- Bayer AG
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Lumenis Ltd.
- Medimetriks Pharmaceuticals Inc.
- TheOTCLab B.V.
- Xian Janssen Pharmaceutical Ltd.
- Other key players
Our Clients
Kickstart 2026 with Exclusive Savings
✖
Request a Sample Report
We'll get back to you as quickly as possible